Last updated on December 2017
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis.
Brief description of study
This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC).
Stipend range: $75o/v, $100proc
For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 additional weeks.
Clinical Study Identifier: TX154995
Start Over
Connect »